HIT Consultant November 14, 2024
As the digital health market continues to expand—projected to grow from nearly $250 billion in 2023 to over $815 billion by 2030—it’s essential to reassess how we measure its success. The prevailing focus on ROI has driven much of this sector’s growth. In fact, a recent survey revealed that 94% of investors prioritize ROI over clinical evidence when evaluating digital health tools. The data backs it up; 82% of healthcare and life sciences companies note significant or moderate revenue increases when incorporating mature AI. However, the conventional metrics of cost savings and revenue growth are missing an opportunity to capture the true value of digital health innovations as well has healthcare transformation as a whole. Compounding this problem is the...
Today's Sponsors
Today's Sponsor